MUCOMYST Drug Patent Profile
✉ Email this page to a colleague
When do Mucomyst patents expire, and when can generic versions of Mucomyst launch?
Mucomyst is a drug marketed by Apothecon and Mead Johnson and is included in two NDAs.
The generic ingredient in MUCOMYST is acetylcysteine; isoproterenol hydrochloride. There are three drug master file entries for this compound. Additional details are available on the acetylcysteine; isoproterenol hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MUCOMYST?
- What are the global sales for MUCOMYST?
- What is Average Wholesale Price for MUCOMYST?
Summary for MUCOMYST
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 157 |
| Clinical Trials: | 19 |
| Patent Applications: | 3,580 |
| DailyMed Link: | MUCOMYST at DailyMed |
Recent Clinical Trials for MUCOMYST
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | Phase 4 |
| Chang Gung Memorial Hospital | N/A |
| Chang Gung University | N/A |
US Patents and Regulatory Information for MUCOMYST
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apothecon | MUCOMYST | acetylcysteine | SOLUTION;INHALATION, ORAL | 013601-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Apothecon | MUCOMYST | acetylcysteine | SOLUTION;INHALATION, ORAL | 013601-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mead Johnson | MUCOMYST W/ ISOPROTERENOL | acetylcysteine; isoproterenol hydrochloride | SOLUTION;INHALATION | 017366-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
